TABLE 2.

Univariate model for predicting the length of stay of patients in ED

Variabled	Estimatea	95% CIe	P valueb
Age	0.06	−0.50 to 0.63	0.82
Sex	−8.97	−32.5 to 14.5	0.46
SARS-CoV-2-positive test	−1.47	−35.3 to 32.4	0.93
Rapid test indication comorbidities	−18.69	−42.1 to 4.70	0.12
HIV	25.83	−35.34 to 87.00	0.41
Diabetes	−4.26	−36.40 to 27.87	0.80
Renal failure	23.80	−21.13 to 68.73	0.30
Heart failure	−24.09	−93.95 to 45.76	0.50
Hypertension	31.78	5.42 to 58.14	0.02
Active cancer	−1.45	−31.02 to 28.11	0.92
Graft	39.10	−29.00 to 107.2	0.26
Obesity	0.18	−75.80 to 76.15	0.99
Clinical signs
Dyspnea	−2.65	−30.78 to 25.49	0.85
Asthenia	23.13	−60.30 to 14.05	0.22
Sore throat	−73.93	−161.22 to 13.35	0.10
Ageusia/anosmia	−120.307	−234.0 to −6.58	0.04
Headache	−4.73	−53.68 to 44.21	0.85
Myalgia	−34.75	−84.21 to 14.72	0.17
Nausea/vomiting	4.27	−40.70 to 49.23	0.85
Diarrhea	23.38	−25.54 to 72.30	0.35
Cough	−9.18	−43.49 to 25.14	0.60
Fever	−4.19	−32.92 to 24.54	0.78
No. of symptoms	−4.96	−13.80 to 3.89	0.27
No. of patients per day	1.67	0.79 to 2.55	<0.001
Hourly occupation rate	9.29	5.72 to 12.85	<0.001
Period b	−69.39	−91.89 to −46.89	<0.001
Daytime c	0.36	−2.26 to 2.99	0.79

^aEstimates are expressed in minutes.

^bPeriod corresponds to the effect of the IDNOW implementation.

^cDay shift (8:00 a.m. to 6:00 p.m.) versus night shift (06:00 p.m. to 08:00 a.m.).

^dData with significative differences are indicated in bold.

^eCI, confidence interval.